Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Montelukast 10 mg Tablets (Singulair vs Montelukast GPO) in Healthy Thai Volunteers under Fasting Conditions
TCTR20170119002Phase 1Completed
- Sponsor
- Government Pharmaceutical Organization
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by Government Pharmaceutical Organization. Started Apr 2017; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20170119002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170119002.